价格

SANOFI WINTHROP INDUSTRIE

130 RUE DE LA FONTAINE, Amilly, Centre Val De Loire, 法国

概览

试验阶段分布

阶段

试验数

占比

1 期

33.3%

2 期

33.3%

4 期

33.3%

试验状态分布

进行中（未招募）

33.3%

已完成

33.3%

招募中

33.3%

药物批准

按机构分类的批准

NMPA

National Medical Products Administration

药物批准

EMA

European Medicines Agency

药物批准

PHILIPPINES

Philippines FDA

药物批准

SFDA

Saudi Food and Drug Authority

药物批准

NPRA

National Pharmaceutical Regulatory Agency

药物批准

CIMA_AEMPS

Spanish Agency for Medicines and Medical Devices

117

药物批准

近期批准

SOLIAN 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

CIMA_AEMPS

2026-09-01

NUVAXOVID JN.1 DISPERSION INYECTABLE EN JERINGA PRECARGADA

CIMA_AEMPS

2026-08-11

CENRIFKI 60 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

CIMA_AEMPS

2026-08-06

KARVEZIDE 300 MG/12,5 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

CIMA_AEMPS

2026-06-11

SARCLISA 1 400 MG SOLUCION INYECTABLE

CIMA_AEMPS

2026-06-08

REZUROCK 200 MG COMPRIMIDOS RECUBIERTOS CON PELICULA

TEIZEILD 1 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

RENVELA (SEVELAMER CARBONATE) TABLET 800MG

NPRA

2025-11-28

资讯

暂无资讯文章

返回机构列表

SANOFI WINTHROP INDUSTRIE

概览

试验阶段分布

试验状态分布

相关临床试验

该机构主办的试验（3）

Avalglucosidase alfa French post-trial access for participants with Pompe disease

A Study to evaluate safety and tolerability of olipudase alfa in pediatric and adult participants with Acid sphingomyelinase deficiency (ASMD) who completed the DFI12712 or the LTS13632 Study in France

Avalglucosidase alfa French post-trial access for participants with Pompe disease

药物批准

按机构分类的批准

近期批准

资讯